DDR1 Regulates Femoral Arterial Calcification in Lower-Extremity Artery Disease Through NF-Kappa B Activation

Manovriti Thakur1,2, Thibaut Quillard3, Nico Angliker1,2

  • 1Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

PubMed

Insights

This study identifies DDR1 as a key driver of medial arterial calcification (MAC) in lower-extremity arterial disease (LEAD). Targeting DDR1 may offer a novel therapeutic approach to prevent MAC in LEAD patients.

Area of Science:

  • Vascular Biology
  • Cardiovascular Disease Research
  • Molecular Medicine

Background:

  • Lower-extremity arterial disease (LEAD) affects 230 million globally, with medial arterial calcification (MAC) common in patients and linked to mortality.
  • Current therapeutic strategies for femoral MAC in LEAD are lacking, and its underlying mechanisms require elucidation.
  • Understanding the molecular drivers of femoral MAC is crucial for developing targeted treatments.

Purpose of the Study:

  • To identify molecular drivers of femoral medial arterial calcification (MAC) in patients with lower-extremity arterial disease (LEAD).

Main Methods:

  • Analysis of human patient samples using von Kossa staining, immunofluorescence, and gene expression.
  • Assessment of medial calcification in Apoe-/- mice fed a Western diet (WD).
  • In vitro experiments with murine and human vascular smooth muscle cells (VSMCs) to evaluate DDR1's role in calcification.

Main Results:

  • Femoral arteries showed significantly higher calcification and pro-calcifying gene expression (DDR1, BMP2) compared to carotids.
  • DDR1 expression positively correlated with calcification in human femoral samples.
  • DDR1 inhibition reduced, while activation increased, calcium deposition in VSMCs; DDR1 stimulation activated NF-κB, a pathway implicated in calcification.

Conclusions:

  • DDR1 is identified as a key molecular driver of calcification in LEAD, operating via NF-κB activation.
  • Targeting DDR1 presents a potential novel therapeutic strategy for preventing medial arterial calcification in LEAD.
  • Further research into DDR1 inhibition could lead to new treatments for atherosclerotic cardiovascular disease manifestations.
Abstract

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
288
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
318